[Steroid hormone receptors and survival in breast cancer patients].
Estrogen receptor (ER) levels were measured in 280 breast cancer patients (mean age 54.5 years). Progesterone receptor (PR) levels were assayed in 101 of them. 61.4% of cases were at stages I and IIa. No significant difference in 2-year survival was established between ER-negative and ER-positive patients (96.7 and 96.0%, respectively). Two-year survival rate and recurrence--free survival for PR-positive cases were significantly higher than those for PR-negative ones (p greater than 0.05).
D001943:Breast Neoplasms / Q000032:analysis* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy; D009367:Neoplasm Staging; D011379:Prognosis; D011959:Receptors, Estradiol / Q000032:analysis*; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone
Retseptory steroidnykh gormonov i vyzhivaemost' bol'nykh rakom molochnoĭ zhelezy.